Efficacy and Safety of Milk Secretory Supplement in Breast-feeding Volunteers

NCT ID: NCT05880589

Last Updated: 2023-05-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-08

Study Completion Date

2023-11-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study are to evaluate efficacy and safety of milk secretory supplement containing fenugreek, banana flower, and ginger extract in breast-feeding volunteers

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There are 24 volunteers in this study. They are randomly divided into 2 groups which are milk secretory supplement group and placebo group. The volunteers take 2 tablets of the sample 2 times/day for 14 days. Amount of breast milk, calcium, iron, docosahexaenoic acid, quality of life, adverse reaction, and satisfaction before taking and after taking for 14 days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lactation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Milk secretory supplement

Milk secretory supplement composes of fenugreek, banana flower, ginger extract, docosahexaenoic acid, iron, folate, and iodine.

Group Type EXPERIMENTAL

Milk secretory supplement group

Intervention Type DIETARY_SUPPLEMENT

Take 2 tablet 2 times per day for 14 days

Placebo group

Placebo is tablet without fenugreek, banana flower, ginger extract, docosahexaenoic acid, iron, folate, and iodine.

Group Type PLACEBO_COMPARATOR

Placebo group

Intervention Type DIETARY_SUPPLEMENT

Take 2 tablet 2 times per day for 14 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Milk secretory supplement group

Take 2 tablet 2 times per day for 14 days

Intervention Type DIETARY_SUPPLEMENT

Placebo group

Take 2 tablet 2 times per day for 14 days

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* During lactation
* Using only breast pump
* No taking medicine or dietary that has an effect on milk secretary including domperidone, banana flower, fenugreek, and ginger in 48 hours
* No smoking and alcohol drinking
* Can read and write in Thai language
* Can meet researcher at the date of appointment
* No complication after delivering

Exclusion Criteria

* Have uncontrolled diseases, cancer, or heart disease
* Have immunocompromised disease or use steroid in 2 weeks
* Allergic to fenugreek, banana flower, ginger, docosahexaenoic acid, iron, folate, and iodine
* Cannot follow the protocol
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chulalongkorn University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pornanong Aramwit, Pharm.D., Ph.D

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pornanong Aramwit, Professor

Role: PRINCIPAL_INVESTIGATOR

Chulalongkorn University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pornanong Aramwit

Bangkok, , Thailand

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pornanong Aramwit, Professor

Role: CONTACT

+66899217255

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pornanong Aramwit, Professor

Role: primary

+66899217255

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SIRB710/2565

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Breastfeeding Intervention Study
NCT02016586 COMPLETED NA
Community Interventions to Improve Breastfeeding
NCT05503069 ACTIVE_NOT_RECRUITING NA
Pompe Lactation Sub-Registry
NCT00566878 COMPLETED